349
Monte Rosa Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
276
FY23:
236
FY24:
377
FY25:
393
(positive)
Change from FY21 to FY25
millions USD
FY21:
17.7
FY22:
66.5
FY23:
67.5
FY24:
61.3
FY25:
55.5
Total assets
Change from FY21 to FY25
millions USD
FY21:
366
FY22:
342
FY23:
304
FY24:
439
FY25:
449
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
16.6
FY22:
25.6
FY23:
46.6
FY24:
157
FY25:
64.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.18
FY22:
45.4
FY23:
77.9
FY24:
58.9
FY25:
151
(positive)
Change from FY21 to FY25
millions USD
FY21:
348
FY22:
271
FY23:
179
FY24:
223
FY25:
233
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
366
FY22:
342
FY23:
304
FY24:
439
FY25:
449
All amounts in millions USD